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Mouse-human chimeric antibodies composed of murine variable (V) and human (C) chains are useful therapeutic reagents.
Consequently, we investigated whether heterologous C-regions from mice and humans affected specificity and affinity, and
determined the contribution of CH glycosylation to antigen binding. The interaction of a 12-mer peptide mimetic with
monoclonal antibody (mAb) 18B7 to Cryptococcus neoformans glucuronoxylomannan, and its chimeric (ch) and
deglycosylated forms were studied by surface plasmon resonance. The equilibrium and rate association constants for the
chAb were higher than for mAb 18B7. V region affinity was not affected by CH region glycosylation whereas heterologous C
region of the same isotype altered the Ab binding affinity and the specificity for self-antigens. Structural models displayed
local differences that implied changes on the connectivity of residues. These findings suggest that V region conformational
changes can be dictated by the CH domains through an allosteric effect involving networks of highly connected amino acids.
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INTRODUCTION
Monoclonal antibodies have found a wide range of applications in
vitro for immunochemical characterization and quantization of
antigens (Ags) as well as many different therapeutic applications,
for the treatment of microbial, autoimmune and malignant
diseases. Although several murine mAb are in clinical use, their
use is limited because treated patients develop human anti-murine
antibodies (HAMA) that may reduce the effectiveness of a
treatment due to the formation of immune complexes. Ideally,
human Abs would be used in therapy but these remain difficult to
produce. One alternative is the construction and production of
mouse-human chAbs. These molecules have human C regions to
provide effector functions and mouse V regions that bind antigen.
Since the C region constitutes most of the mass of the
immunoglobulin (Ig), chAbs are largely human in composition
and significantly less immunogenic. However, a central assump-
tion in the construction and use of mouse-human chAbs is that
they retain the affinity and specificity of the parental murine mAb.
Although this assumption is supported by an overwhelming
amount of data showing that V regions interact with Ag, there is
now considerable data that the C region can affect V region
structure therefore affecting Ab affinity and specificity [1–6]. In
this regard, the different CH domains can impose diverse structural
constrains to the interaction of Ab with Ags, especially multivalent
Ags such as polysaccharide. This raises the question of whether
similar effects can follow the construction of mouse-human
chimeric antibodies where heterologous C regions manifesting
differences in sequence are exchanged to create a less immuno-
genic molecule.
The murine mAb 18B7 is being developed as an adjunctive
passive immunotherapy treatment of cryptococcal meningitis in
patients with AIDS [7]. Infusion of mAb 18B7 into patients
induced HAMA responses, despite their immunosuppressed status
[7]. Since cryptococcosis is a chronic disease, there is interest in
generating therapeutic Ab reagents that are non-immunogenic
and suitable for multiple infusions. Given that the murine mAb
18B7 has undergone clinical testing and that has been extensively
studied in the laboratory, one approach was to generate chAbs as
potential therapeutic reagents, with the assumption that expression
of mAb 18B7 V regions in combination with human C regions
would maintain the specificity and affinity of the murine mAb.
That assumption was challenged by the observation that a set of
mouse-human chAbs derived from mAb 18B7 [8] to the capsular
polysaccharide of C. neoformans glucuronoxylomannan (GXM),
manifested subtle differences in their binding characteristics [1].
Furthermore, there is extensive anecdotal and unpublished
evidence that many attempts to generate humanized mAbs based
on mouse V regions have failed to produce useful Abs because of
loss of specificity or affinity. However, the available data are only
suggestive since one can always blame differences in avidity
resulting from different hinge region geometry for differences in
the binding of chAbs relative to the parental murine mAb.
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PLoS ONE | www.plosone.org 1 December 2007 | Issue 12 | e1310In this study, we used surface plasmon resonance (SPR) to
investigate the thermodynamic and kinetic properties of binding of
the GXM-binding mAb 18B7, its deglycosylated form (18B7dg) and
its mouse-human chAb counterpart. These Abs have identical V
regions but differ in their C domains. Most of the Ig glycosylation
sites are found in the CH domains but glycosylation seems to have
little if any effect on Ab binding to Ag [9,10]. Comparison of the
binding kinetics and thermodynamics between the glycosylated and
deglycosylated murine mAb 18B7 forms and the chAb 18B7
revealed differences in binding affinity attributed to the heterologous
CH region, however no contribution from the carbohydrate motif
was observed. The results have important implications for the design
and use of heterologous V and C chains in therapeutic Abs.
RESULTS
Effect of glycosylation and heterologous constant
region on the kinetic and equilibrium binding
constants
To study the role of glycosylation we compared mAb 18B7, chAb
18B7, and 18B7dg binding to the GXM mimetic peptide P1.
Analysis of these mAbs by SPR revealed that the association rate
constants for the encounter step (k+1) for mAb 18B7 and 18B7dg
were similar, but different from chAb 18B7 (Figure 1A). The
equilibrium dissociation constants (KD) for mAb 18B7, 18B7dg
and chAb 18B7 are 2.33610
23, 1.07610
23 and 5.41610
24 Ma t
25uC, respectively. Van’t Hoff plots of the interaction of these Abs
with peptide P1 revealed that their affinity decreased with
temperature (Figure 2A). In addition, the equilibrium association
constants for the binding of mAb 18B7 and its deglycosylated form
to P1 manifested similar affinity constants and their binding
characteristics were more influenced by the change in temperature
than that observed for chAb 18B7 (Figure 2A). It is also
noticeable that chAb 18B7 had a higher overall equilibrium
affinity constant (KA) than the parental mAb 18B7. In addition, for
all these complexes, the encounter equilibrium association
constant Ka1 showed a pattern that is almost identical to the
equilibrium association constant (Figure 2B), while the docking
equilibrium association constant Ka2 was relatively unaffected by
changes in temperature, showing similar trends between Ab-
peptide complexes (Figure 2C).
Effect of glycosylation and heterologous constant
region on the thermodynamic parameters of Ab
binding
Analysis of the Gibbs free energy of binding (DG) profiles of these
mAb-peptide complexes showed that for mAb 18B7 and its
deglycosylated form, the energy of binding increases with temper-
ature, followed by a decrease at temperatures above 30uC( 3 0 3K ) ,
whereas the energy of binding for chAb 18B7-P1 complex was
relatively insensitive to temperature changes (Figure 3A). A similar
pattern was observed for the encounter energy of binding (DG1)
(Figure 3B) for the complexes formed by mAb 18B7 and 18B7dg
andchAb18B7relativetoDG.Thedockingenergyofbinding(DG2)
increased slightly at low temperatures, but remained otherwise
relatively insensitive to changes in temperature, and manifested
similar patterns for all Ab-peptide complexes (Figure 3C). From
these data, we can establish that most of the free energy changes
come from the encounter step. Furthermore, DSf o rm A b1 8 B 7a n d
its deglycosylated form decreased as the temperature increased
(Figure 3D), but showed a sharp increase above 30uC( 3 0 3K ) .I n
contrast, DS for the chAb 18B7-P1 complex decreased only slightly
with increasing temperature (Figure 3D). Also, differences in DG
(DDG) of mAbs 18B7dg and chAb 18B7 relative to mAb 18B7
indicate the interaction formed by chAb 18B7 is energetically more
favorable than for mAb 18B7dg (Figure 4A), with contributions to
the differences in energy of binding coming from the encounter and
docking steps (Figure 4B and 4C). Interestingly, for the chAb
18B7-P1 and 18B7dg-P1 complexes, most of the contributions to
activation energy of the transition state DDG
? (Figure 5A) are from
the encounter step DDG1
? (Figure 5B). Hence, deglycosylation
leads to differences in the energies of binding with respect to the
glycosylated form. These differences are more accentuated for the
encounter activation energy of chAb 18B7, indicating that the
transition state for this complex is energetically more favorable than
for the mAb 18B7dg-P1 complex at temperatures ranging from
20uCt o3 5 uC (293 K to 308 K). In summary, kinetic and
thermodynamic calculations indicate that deglycosylation does not
affect the affinity of binding, but a heterologous associated C region
will, as shown above.
Molecular modeling analysis
At a first glance, the backbone conformation of mAb 18B7 and
chAb 18B7 models differed significantly (Figure 6A). However, a
detailed analysis showed that these changes were due to different
Ab elbow angles, i.e. angle between variable (VL and VH) and C
domains (CL and CH1). If any of the two domains, V or C, for any
of the chains, H and L, is kept fixed during structural superposi-
tion, a good structural agreement can be observed (L chain:
Figure 6B and 6C keeping VL and CL fixed during structural
superposition; H chain: Figure 6D and 6E superposing domain
VH and CH1 respectively).
Analysis of the connectivity of the Fab for murine mAb 18B7 and
chAb 18B7 showed that these differences were located mainly at the
interface between the CH and VH domains (Figure 7A and 7B).
Highly connected residues (i.e. Zscore$1.5) were assembled forming
a network that spans from the CH1 domain to the VH domain. This
network can provide a logical explanation for a long-range allosteric
effect that involves residue-to-residue communication. It is worth
noting that Phe
103 (Figure 7B) is located in one of the CDRs loop
and the network of highly connected residues extends to the CH1
domain. Figure 7C shows the sequence alignment and the
connectivity analysis; chAb 18B7 and mAb 18B7 display a differential
connectivity pattern. This difference in connectivity pattern could
explain the differential affinity of mAb 18B7 and chAb 18B7 toward
an Ag. The analysis also suggests that these conformational variations
are a consequence of species class-specific constraints.
Polyreactive patterns of Abs 18B7
The polyreactive properties of mAb 18B7, 18B7dg and chAb
18B7 were measured by a panel of self-antigens consisting of actin,
tubulin, thyroglobulin, and single-stranded DNA (Figure 8A–D).
Polyreactivity was evident among these mAbs, showing differences
in binding reactivity within the Ags used for the study. It is
noticeable that chAb 18B7 has an overall lower binding reactivity
for the self-Ags used in this study, in accordance with differences in
specificity for this Ab with respect to mAb 18B7. In addition, we
have shown that cross-reactivity does not only occur with closely
related molecules because the studied cross-reactants are not
related to the capsular polysaccharide GXM.
DISCUSSION
In previous studies, we established that a family of V-region
identical murine IgG1, IgG2a, IgG2b, and IgG3 manifested
diverse binding affinity and specificity that were attributed to C
region effects on the V region. This effect was attributed to amino
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attached V region that translated into variations in antigen
binding [11]. An implication of those results was that chAbs might
also manifest differences in Ag binding as a consequence of amino
acid sequence dissimilarities between heterologous C regions.
Consistent with this notion a prior study comparing the binding of
mAb 18B7 derived chAbs revealed differences in Ag binding but
the results were only strongly suggestive, since avidity contribu-
tions resulting from Ab geometry and flexibility could have
influenced the types of Ab-Ag complexes formed [1]. To
rigorously establish whether heterologous C regions affected V
region interactions with Ag it was necessary to use an experimental
system whereby each V region interacted with only one epitope to
avoid avidity contributions combined with a sensitive measure for
detecting binding differences. To investigate the characteristics of
binding we used SPR, a method that can detect the interaction of
mAb immobilized on a sensor chip with a small antigen such as a
peptide, thus avoiding avidity contributions and allow examination
of the kinetics and thermodynamics of Ab-Ag complex formation.
A characteristic of all IgGs is glycosylation in the CH2 domain at
Asn
297 [12], which is necessary for structure recognition and
stability [13], and several effector functions, such as complement
binding and activation, and interactions with Fc receptors [14–
18]. Glycosylation can affect the conformation of some Ab
molecules by increasing or decreasing the stability of amino acid
residues in the Ag binding site [19,20]. Furthermore, numerous
studies have shown that CH2 domain associated oligosaccharides
play an essential role in IgG1-mediated Ab effector function
[14,15,21–23]. However, few studies have addressed the issue of
how differences in the structure of the CH domains influence Ab-
Ag binding [15].
Given the differences observed in binding affinities for the Fab
molecules observed in our previous work [11], we could not rule out
contributions of the CH2 domain to the Ab-Ag interaction. We have
approached this issue by removing glycan chains using endoglyco-
sidase digestion with a method known to be very effective in
deglycosylating this mAb [24]. mAb 18B7 has a conventional IgG
glycosylation pattern with a single N-linked glycosylation at Asn
263
residue [24]. Circular dichroism spectral analysis of parental mAb
18B7 and 18B7dg revealed no major change in the secondary
structureas a resultof N-glycanremoval,and their binding patternsto
C. neoformans are essentially identical [24]. Native and deglycosylated
mAb 18B7 binding to peptide P1 manifested similar binding kinetics
and thermodynamics, suggesting that structural changes imparted
upon CH2 domain by glycosylation do not extend into the V region
and had little or no effect on the binding site of the murine IgG1used
for this study. This result is consistent with, and complementary of,
the findings observed with anti-GXM mAbs 3E5, in that most of the
isotype-related contributions to V-region binding affinity are a result
of conformational changes on the CH1 domain, rather than CH2 [11].
In contrast to the similar interactions measured for the native
and deglycosylated murine mAb 18B7, we found significant kinetic
and thermodynamic differences in the comparison between mAb
18B7 and chAb 18B7. The V region of mAb 18B7 manifested a
higher binding affinity when attached to a human c1 chain. chAb
18B7 had a greater affinity, as determined by the equilibrium
association constant than the parental murine mAb and different
kinetics of binding, suggestive of differences in their fine specificity.
These results imply that the nature of the C region electrostatic
and hydrophobic interactions with the attached V region
modulates the affinity and specificity of binding to Ag among
Abs with an identical variable region. Consistent with these
Figure 1. Analysis of the association and dissociation rates constants by SPR. Van’t Hoff plots of the rate constants A,k +1, B,k 21, C,k +2 and D,k 22
for mAb 18B7, 18B7dg, and chAb 18B7 binding to peptide P1. All data points were obtained from the BIAevaluation 4.1 software using a two-state
model. Lines represent the best fit to a linear regression using a 95% confidence interval. Errors bars were calculated using propagation of error for SE
of each assay.
doi:10.1371/journal.pone.0001310.g001
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can be influenced by regions adjacent to the V domains [25,26].
The stability of Ab-Ag complexes is regulated by the same forces
asin otherbiological structures,namely electrostaticinteractionsand
the hydrophobic effect [27,28]. The structural modeling revealed
thatm18B7and ch18B7 are structurallyverysimilar,predicting only
changes in the Ab elbow angles. Prior studies have speculated that
the elbow angles might change in response of ligand binding [29],
but no convincing experimental data has been found to support that
hypothesis [30]. We favor the view that conformational differences
imposed by the CH1 domain on the Ag-binding site could affect
binding affinity and specificity. These conformational differences are
probably a result of small changes in the electrostatic interactions
between amino acid residues rather than by ‘gross’ conformational
changes caused by hinge flexibility or by structural constrains
imposed by the oligosaccharide moieties [31,32].
Identifying functional residues is a complex issue. Activity can
be modulated by residues that are distant from the binding site and
these interactions within and between functional sites are crucial
for protein activity. The study of closeness values in protein
structure has proved useful in characterizing functional sites [33].
Such studies are also useful for describing the interaction networks
within protein structures that are connected to active site residues,
as those found in enzymes where effectors bind to residues distant
from the active sites. Central residues have high closeness values
and they are assumed to transmit and efficiently integrate in
formation to the rest of the protein [33]. Our earlier studies [11]
suggested that highly connected residues may be involved in the
differences in fine specificity in four murine mAbs expressing
different CH regions and identical V regions. As observed in the
homology models, an electrostatic network between the tyrosines
residues interacting at the interface of the V region and the CH1
domain of murine mAb 18B7 could be more unfavorable for the
net electrostatic forces of binding. These interaction networks
formed at the CH1 domain appear to be directly responsible for the
differences in affinity and specificity between these mAbs.
The differences observed in the specificity of these mAbs also
affected the characteristics of binding to a panel of self-antigens,
indicating that polyreactivity is not only preserved after Ig class
switch [34], but it also depends on the contribution of structural
changes caused by the CH domains. This finding implies that
polyreactivity is influenced by the surrounding CH structures,
possibly making the Ab-combining site more plastic, thus allowing
these Abs to recognize a variety of Ags. Consequently, the
structural heterogeneity conferred by the different CH regions may
result in the production of polyreactive Ab by changing charge
and/or hydrophobicity of the V region. This implies that mouse-
human chAb construction may yield Igs with binding character-
istics that are different from the parental murine mAb, including
the possibility for unexpected self-reactivity.
In summary CH region glycosylation does not affect Ag binding,
but exchanging murine and human CH domains can have
profound effects on affinity and specificity. Although the
generalizability of the observations with mAb 18b7 and chAb
18B7 to other chimeric Abs is unknown, our findings suggest
caution with assuming that simply replacing the C region domain
maintains the specificity and affinity of the V region. Given that
different V region genes encode for proteins with differences in
protein sequence, Abs encoded by different V region genes may
vary in their susceptibility to C region structural effects.
Furthermore, we anticipate that these effects might also be
expected to occur in chAbs composed of human V and mouse C
regions [35]. Substituting the mouse C regions with human C
regions in chAbs was a major advance in reducing the
immunogenicity of mouse mAbs but our results show that this
approach can have unpredictable effects on the thermodynamics
of Ag-Ab complexes and the self-reactivity of chAbs. We do not
know if the new reactivities exhibited by chAb 18B7 relative to the
parent mAb 18B7 are clinically relevant, but the fact that
polyreactivity occurs is the need for additional caution when
examining the potential for cross-reaction with host tissues. Since
most of the Abs currently used in drug therapy are of the IgG1
Figure 2. Equilibrium affinity constants for the binding of mAb 18B7,
18B7dg, and chAb 18B7 to peptide P1. Van’t Hoff plots of the A,
equilibrium association constant (KA), B, encounter equilibrium
association constant (Ka1) and C, docking equilibrium association
constant (Ka2) for mAbs 18B7 binding to peptide P1. All equilibrium
constants were calculated from the rate constant obtained from the
fittings to a two-state model. Lines represent the best fit to a linear
regression using a 95% confidence interval. Errors bars were calculated
using propagation of error for SE of each assay.
doi:10.1371/journal.pone.0001310.g002
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chain affects murine V region binding affinity and specificity. An
improved understanding of the mechanisms underlying this effect
may allow the design of less immunogenic Abs for therapeutic use
that maintain greater Ag-binding fidelity and lower polyreactivity.
METHODS
MAbs and peptides
GXM-binding mAb 18B7 was made from a mouse immunized with
a GXM-Tetanus Toxoid conjugate vaccine [8]. Mouse-human
chAb 18B7 (IgG1) was generated by cloning and transfection as
described [36]. mAb 18B7 was purified by protein G affinity
chromatography (Pierce) from hybridoma culture supernatants, and
dialyzed against at least two changes of PBS. Mouse-human chAb
18B7 was purified by protein L agarose beads (Sigma). mAb 18B7
was deglycosylated as described [24]. Briefly, 337 mg of mAb 18B7
were incubated at 37uC for 24 h with 100 mU of PNGaseF (Glyco).
Then, the digestion mixture was dialyzed against at least two PBS
changes. All Abs were analyzed by polyacrylamide gel electropho-
resis to verify their integrity and correct molecular weight. Ab
concentration was determined by ELISA and Bradford measure-
ments. Peptide mimetic of GXM P1 (SPNQHTPPWMLK) [3] was
synthesized and biotinylated by the Laboratory for Macromolecular
Analysis at the Albert Einstein College of Medicine.
Immobilization of mAb 18B7, 18B7dg and chAb 18B7
The BIAcore 3000 system and the research grade sensor chip
CM5 (BIAcore) were used. mAbs were immobilized in the surface
of the CM5 chip through primary amino groups using reactive
esters. First, the carboxylated matrix was activated with 70 mlo fa
1:1 mixture of N-ethyl-N9(dimethylaminoporpyl)-carbodiimide
(EDC) (Pierce) and N-hydroxysuccinimide (NHS) (Pierce). Then,
mAbs 18B7 and 18B7dg were injected at 25 mg/ml in 10 mM 2-
(N-morpholino) ethanesulphonic acid (MES) (Sigma-Aldrich),
pH 6.0. chAb 18B7 was injected at 25 mg/ml in 10 mM sodium
acetate (Sigma-Aldrich), pH 5.42. After mAb injection, remaining
NHS-ester groups were blocked by injection of 70 mlo f1 M
ethanolamine (Sigma-Aldrich), pH 8.5.
Kinetic Measurements
To analyze the kinetic and thermodynamic parameters of the Abs
utilized in this study we used the peptide mimetic of GXM P1 [3].
The interaction of the mAbs-peptide complexes was analyzed at 10,
15, 20, 25, 30, and 35uC. Peptide P1 was tested at concentrations
ranging from 1.56 mMt o2 0 0mM at high flow rate (100 ml/min) in
0.2 mM K2HPO4/KH2PO4 pH 6.5, 150 mM KCl and 0.01%
Tween 20. At the end of the dissociation phase the surface was
regenerated by injecting 50 ml of 50 mM ethanolamine in 50%
ethylene glycol (Sigma-Aldrich) and 50 mlo f1 0 m MH C l .A n
unmodified dextran surface was used as reference. Kinetic data was
analyzed with the BIAevaluation 4.1 software. Data for each group
was analyzed globally using a two-state model to obtain the forward
(k+1,k +2) and reverse (k21,k 22) rate constants. The rate constants for
each global fit were used to calculate the association equilibrium
constant, based on the following equations:
Ka1~kz1=k{1 and Ka2~kz2=k{2 ð1Þ
KA~Ka1 1zKa2 ðÞ ð 2Þ
The Gibbs free energy changes DG were calculated from the
Figure 3. Thermodynamics of binding of mAbs 18B7, 18B7dg and chAb 18B7 to a peptide mimetic of GXM. Behavior of A, free energy of binding
(DG), B, encounter free energy of binding (DG1), C, docking free energy of binding (DG2) and D, entropy of binding (DS) as a function of temperature
for the mAb 18B7, 18B7dg and chAb 18B7 binding to peptide P1. Free energies were calculated from the formula DG=2RT ln KA, DG=2RT ln Ka1,
DG=2RT ln Ka2 and DS from the formula DG=DH2TDS.
doi:10.1371/journal.pone.0001310.g003
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DG~{RT lnKA ð3Þ
DG1~{RT lnKa1 and DG2~{RT lnKa2 ð4Þ
DG~DH{T DS ð5Þ
These equations can be rearranged to yield the relation:
lnKA~{DH=RTzDS=R ð6Þ
BymeasuringKA asa function of temperature,one canplotlnKD
versus 1/T (eq. 6). Ideally, this plot, known as van’t Hoff plot, should
yield a straight line with a slope of 2DH/R and an intercept DS/R.
Enthalpy changes (DH) were calculated from the slope of the van’t
Hoff plot. Entropy changes (DS) were calculated from the equation
5, by substituting the values of DG (eq. 3) and assuming a constant
DH with temperature. Equilibrium constants were calculated
without considerations of the errors of the rate constants.
Figure 4. Effect of temperature on the differences in free energy of
binding (DDG) of chAb 18B7 and 18B7dg complexes. Each panel
corresponds to the DG of chAb 18B7-P1 and 18B7dg-P1 complex
formation, relative to the DG of parental mAb 18B7, at different
temperatures. A, overall difference of the free energy of binding (DDG)
and overall difference of the free energy of binding of B, encounter and
C, docking steps (DDG1 and DDG2) for the mAbs 18B7dg and chAb
18B7 at 35uC, 30uC, 25uC, 20uC, 15uC, 10uC. Values of DDG were
calculated as DGch/dgAb2DGmAb18B7.
doi:10.1371/journal.pone.0001310.g004
Figure 5. Differences in free activation energy of binding (DDG
{)o ft h e
transition states of chAb 18B7 and 18B7dg for the binding to peptide
P1. Each panel corresponds to the DG of chAb 18B7-P1 and 18B7dg-P1
complex formation, relative to the DG of parental mAb 18B7. A,f r e e
activation energy of binding (DDG
{), B, encounter activation free energies
(DDG1
{)a n dC, docking activation free energies (DDG2
{), as a function of
temperature. Values of DDG were calculated as DGch/dgAb2DGmAb18B7.I n
all cases, the activation energies for the encounter and docking steps
(DG1
{ andDG2
{) were calculated from k+1 and k+2, respectively, according
to the transition state theory: DG
{=2RT ln K
{, DDG
{=2RT ln K
{
ch/dg Ab/
K
{
mAb18B7, and K
{=kB Tk a/h, where ka is the forward rate constant, kB is
Boltzmanns constant and h is Plank’s constant.
doi:10.1371/journal.pone.0001310.g005
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mAb 18B7 and ch18B7weremodeled using thesequence forVHand
VL from mAb 18B7 obtained from the protein GeneBank[37] with
accession numbers AJ309266 and AJ309267, respectively. Each
sequence was used to scan the Protein DataBank (PDB) [38] using
PSI-BLAST [39] with default parameters. PSI-BLAST outputs were
filtered using BlastProfiler [40] to select templates with the highest
sequence coverage and sequence identity. Selected templates were
manually inspected to choose those ones with the highest
crystallographic quality and sequence coverage. The models were
built with M4T [41] combining two experimental structures as
templates for each sequence. A common structure for all sequences
(PDB code 2h1p), was used as template for V and C regions of both L
and H chain; and a specific template for the CH1 domain depending
on the Ab species (PDB codes of 1sbs and 1pz5 CH1 domain, for
human and mouse respectively). The 2h1p structure corresponds to
the experimental three-dimensional structure of anti-GXM mAb
2H1 with peptide mimetic of GXM PA1. The average sequence
identities between target sequences and templates were larger than
90%, assuring high quality models [42,43]. The quality of the models
was assessed using PROSA-II [44] and PROCHECK [45].
Connectivity analysis of residues
Structural models of mAb 18B7 and chAb 18B7, were
transformed into interaction graphs. The nodes of the graphs
are the residues and the edges between nodes are any type of inter-
atomic interactions, namely covalent (peptide bond) and non-
covalent interactions (hydrogen bonds, polar interactions, and
hydrophobic interactions). Inter-atomic interactions were de-
scribed using the CSU program [46]. For each node (or residue)
of the graph a closeness centrality Z-score was calculated as described
in Amitai G. et al [33]. The closeness centrality is a measure of
connectivity; a high closeness centrality value indicates a high
number of interactions with the rest of nodes (or residues).
ELISA
mAb 18B7, 18B7dg and chAb 18B7 were screened for their
polyreactive properties against a panel of antigens by ELISA.
Polystyrene plates were coated overnight at 4uC with actin (Sigma),
tubulin (ICN) and thyroglobulin (Sigma) at 5 mg/ml in bicarbonate
bufferpH 9.6,single stranded(ss)andDNA(Sigma)at100 mg/ml in
sodium citrate buffer, pH 6.0. Plates were blocked with 1% BSA in
TBS for 2 h at 4uC. Abs were added at 40 mg/ml in 1% BSA/TBS
and serially diluted. Plates were incubated overnight at 4uC. Ab
binding was determined with alkaline-phosphatase conjugated goat
anti-mouseH+L(SouthernBiotech)forthemurineAbsandalkaline-
phosphatase conjugated goat anti-human IgG (Caltag) for chAb
18B7. The plates were developed with p-nitrophenyl phosphate
substrate by measuring absorbance at 405 nm.
Statistics
Standard deviations (SD) for the ELISA were calculated using
Microsoft Excel functions for SD. The error bars on the van’t Hoff
plots correspond to the error propagation (ep) of the natural log
Figure 6. Structural models for chAb18B7 (red) and murine mAb18B7 (blue). A, Global structural superposition of the models; light chain depicted
in gray. B, Structural superposition of light chain keeping fixed VL and C,C L domain. Structural superposition of D, heavy chain keeping fixed VH and
E,C H1 domain. Figures 6 and 7 were generated using PyMOL (http://pymol.sourceforge.net).
doi:10.1371/journal.pone.0001310.g006
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PLoS ONE | www.plosone.org 7 December 2007 | Issue 12 | e1310Figure 7. Connectivity analysis of residues in mAb 18B7 and ch18B7 models of CH1 domain. Cartoon representation of A, murine mAb 18B7 VH-CH1
and B, chAb 18B7. Areas of high connectivity are indicted by red and orange (red Zscore.2.0; orange: 1.5#Zscore,2.0); medium connectivity
residues are indicated in yellow (1.0#Zscores,1.5), whereas low connectivity is indicated in blue (Zscore,1.0). Light chain is shown in gray. Side
chains of amino acids with high connectivity values (Zscore$1.5) are indicated by arrow. C, Residues masked in blue in the sequence alignment of H
chain are equal in both Abs (domain VH: 1–120; domain CH1: 121–200). Connectivity values for each residues are shown in the alignment (in form of
histogram and color coding, being b, y, o, and r: blue, yellow, orange, and red respectively); secondary structure elements are also shown.
doi:10.1371/journal.pone.0001310.g007
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PLoS ONE | www.plosone.org 8 December 2007 | Issue 12 | e1310(ep=SEk/k) of the standard error (SE) obtained with the
BIAevaluation software for each rate constant individually.
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